Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics & Biosensors Europe 2018

Point-of-Care Diagnostics & Biosensors Europe 2018

Date: Tuesday, 5 June 2018 - Wednesday, 6 June 2018
Location: Rotterdam, The Netherlands


Conference Chair

Richard Spero

Richard Spero
CEO, Redbud Labs

Keynote Speakers

Arben Merkoçi

Arben Merkoçi
ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST)

Joshua Edel

Joshua Edel
Professor, Imperial College London

Eloisa Lopez-Calle

Eloisa Lopez-Calle
Head Assay Formats, Roche Diagnostics GmbH

John McDevitt

John McDevitt
Chair, Department Biomaterials, New York University College of Dentistry Bioengineering Institute

Emmanuel Delamarche

Emmanuel Delamarche
Manager Precision Diagnostics, IBM Research - Zürich

Amy  Shen

Amy Shen
Professor and Provost, Okinawa Institute of Science and Technology Graduate University

Gregory Timp

Gregory Timp
Keough-Hesburgh Professor of Electrical Engineering & Systems Biology, The University of Notre Dame

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Roger Kamm

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Martyn Boutelle

Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London

Moran Bercovici

Moran Bercovici
Associate Professor, Faculty of Mechanical Engineering; Head, Technion Microfluidic Technologies Laboratory, Technion, Israel Institute of Technology

Jong Wook Hong

Jong Wook Hong
Professor of Bionano Technology and Bionano Engineering, Hanyang University

John Brennan

John Brennan
Professor and Director, Biointerfaces Institute, McMaster University

Overview

Select Biosciences Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.  Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have access to the co-located parallel conference tracks:
  • Lab-on-a-Chip and Microfluidics Europe 2018
  • Organ-on-a-Chip and Tissue-on-a-Chip Europe 2018
The Exhibit Hall is Co-Located with the Conference Tracks and is open 5-6 June 2018.

Information and Local Registration Facilities for this conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Agenda Topics

  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
  • Low Cost POC Diagnostics Platforms for Deployment Worldwide
  • POC Diagnostics for Global Health: A Worldwide Perspective
  • POC Diagnostics in Cardiovascular Disease Testing
  • Point-of-Care Diagnostics in Infectious Disease Testing
  • Wearable and Implantable Devices
  • Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Thomas Brandstetter, Group Leader, University Freiburg
Jane Brock, Chief of Breast Pathology, Brigham and Women’s Hospital, Harvard Medical School
Markus Ebster, Vice President Sales & Marketing, z-microsystems®
Chris Fronczek, Director of Applications, BIODOT, Inc.
Rosanne Guijt, Professor, Deakin University
Alf Månsson, Professor, Linnaeus University and Lund University Sweden
Gökhan Saglam, Project Manager, KOÇ University
Jean-Manuel Segura, Professor, University of Applied Sciences and Arts Western Switzerland Valais
Asma Siari, Technology and Market Analyst, Yole Développement
Collin Sones, Principal Research Fellow/ Associate Professor, University of Southampton
Richard Chasen Spero, CEO, Redbud Labs
Ozlem Yavas, PhD Student, ICFO-Institute of Photonic Sciences


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-06-05 00:00:002018-06-06 00:00:00Europe/LondonPoint-of-Care Diagnostics and Biosensors Europe 2018Point-of-Care Diagnostics and Biosensors Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com